Posts

Showing posts with the label Health Ministry Update

No Scientific Link Between COVID-19 Vaccines and Sudden Deaths, Reaffirms Indian Health Authorities

Image
Government Reiterates: No Direct Link Between COVID-19 Vaccination and Sudden Deaths In a significant development aimed at addressing growing concerns and misinformation, the Union Ministry of Health and Family Welfare has formally clarified that no direct link exists between COVID-19 vaccinations and sudden deaths , particularly among young adults. This assertion is based on comprehensive multi-agency studies conducted by the Indian Council of Medical Research (ICMR) and the National Centre for Disease Control (NCDC) . Studies Conducted Across India to Investigate Sudden Deaths The Ministry, through a detailed press release, informed that the phenomenon of sudden, unexplained deaths—especially in the age group of 18 to 45 years —has been the subject of detailed investigation. Two independent yet complementary studies were launched to explore the root causes: 1. Multicentric Case-Control Study by ICMR-NIE (May–August 2023) Titled “Factors Associated with Unexplained Sudden De...

Health Ministry Introduces New Shorter and More Effective Treatment Regimen for Drug-Resistant TB in India

Image
Health Ministry Introduces New Shorter and More Effective Treatment Regimen for Drug-Resistant TB in India Under the leadership of Prime Minister Narendra Modi and in line with India's goal to eliminate tuberculosis (TB) by 2025, the Union Ministry of Health and Family Welfare has approved the introduction of the BPaLM regimen for treating multi-drug-resistant tuberculosis (MDR-TB). This new regimen promises a more efficacious and shorter treatment duration, making it a breakthrough for the country’s National TB Elimination Programme (NTEP). Introduction of the BPaLM Regimen The BPaLM regimen includes a combination of four drugs: Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin. Among these, Pretomanid, a new anti-TB drug, was previously approved and licensed for use in India by the Central Drugs Standard Control Organisation (CDSCO). The combination of these drugs provides a highly effective, shorter, and safer treatment alternative for MDR-TB patients. This new regimen is a s...